Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jixian Li

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Pharmacology|October 24, 2025
Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patientsLingli Lei, Xiang Zhan, Jixian Li, et al.
Clinical and Experimental Medicine|July 3, 2024
Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinomaXiang Zhan, Jixian Li, Yi Ding, et al.
BMC Pulmonary Medicine|August 29, 2024
Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patientsJianan Li, Wentao Zhang, Yi Zhao, et al.
Frontiers in Medicine|April 2, 2026
Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genesXiang Zhan, Fengge Zhou, Yuanhui Yang, et al.
Journal of Neuro-Oncology|September 9, 2025
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center studyJianxin Zhao, Lijun Liang, Jixian Li, et al.
Journal of Neuro-Oncology|September 19, 2025
Correction to: Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center studyJianxin Zhao, Lijun Liang, Jixian Li, et al.
Frontiers in Neuroscience|January 30, 2023
The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in gliomaZhiyan Xie, Jixian Li, Yue Zhang, et al.
Molecular Medicine (Cambridge, Mass.)|October 26, 2023
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learningYi Zhao, Yanjun Wei, Lingjia Fan, et al.
Molecular Pharmacology|August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Pharmacology|October 24, 2025
Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patientsLingli Lei, Xiang Zhan, Jixian Li, et al.
Clinical and Experimental Medicine|July 3, 2024
Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinomaXiang Zhan, Jixian Li, Yi Ding, et al.
BMC Pulmonary Medicine|August 29, 2024
Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patientsJianan Li, Wentao Zhang, Yi Zhao, et al.
Frontiers in Medicine|April 2, 2026
Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genesXiang Zhan, Fengge Zhou, Yuanhui Yang, et al.
Journal of Neuro-Oncology|September 9, 2025
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center studyJianxin Zhao, Lijun Liang, Jixian Li, et al.
Journal of Neuro-Oncology|September 19, 2025
Correction to: Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center studyJianxin Zhao, Lijun Liang, Jixian Li, et al.
Frontiers in Neuroscience|January 30, 2023
The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in gliomaZhiyan Xie, Jixian Li, Yue Zhang, et al.
Molecular Medicine (Cambridge, Mass.)|October 26, 2023
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learningYi Zhao, Yanjun Wei, Lingjia Fan, et al.
Molecular Pharmacology|August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Pageof 2